Appeal No. 2001-1499 Page 2
Application No. 08/957,654
ulcers and diabetic ulcers comprising a therapeutically effective
amount of alpha-1-antitrypsin.
The references relied upon by the examiner are:
Schwarz et al. (Schwarz) 4,377,572 Mar. 22, 1983
Glover et al. (Glover) 4,829,052 May 9, 1989
Lezdey John et al. (Lezdey) 5,134,119 Jul. 28, 1992
Gillis et al. (Gillis) 5,202,118 Apr. 13, 1993
Clark et al. (Clark) WO 88/00239 Jan. 14, 1988
Rao et al. (Rao), “α1-Antitrypsin Is Degraded and Non-Functional in Chronic
Wounds But Intact and Functional in Acute Wounds: The Inhibitor Protects
Fibronectin from Degradation by Chronic Wound Fluid Enzymes,” J. Invest.
Dermatology, Vol. 105, No. 4, pp. 572-78 (1995)
GROUNDS OF REJECTION
Claim 7 stands rejected under 35 U.S.C. § 102(b) as anticipated by
Schwarz.
Claim 7 stands rejected under 35 U.S.C. § 102(b) as anticipated by
Lezdey.
Claim 9 stands rejected under 35 U.S.C. § 103 as being unpatentable
over Schwarz in view of Clark.
Claims 1-3, 7 and 8 stand rejected under 35 U.S.C. § 103 as being
unpatentable over Gillis.
Claims 1-3, 7 and 8 stand rejected under 35 U.S.C. § 103 as being
unpatentable over Gillis in view of Rao.
Claims 5 and 9 stand rejected under 35 U.S.C. § 103 as being
unpatentable over Gillis in view of Rao and further in view of Clark.
Claim 6 stands rejected under 35 U.S.C. § 103 as being unpatentable
over Gillis in view of Rao and further in view of Glover.
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007